Streck’s first-of-its-kind molecular diagnostics quality control MDx-Chex for BCID2 receives FDA clearance
Streck, a member of Bio Nebraska, announced MDx-Chex™ for BCID2, a first-of-its-kind quality control designed to meet the standards for verifying the performance of the BioFire® BCID2 Panel for sepsis, has been granted FDA clearance for In Vitro Diagnostics Use. Read more